These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2918173)
21. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093 [TBL] [Abstract][Full Text] [Related]
22. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721 [TBL] [Abstract][Full Text] [Related]
23. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM Chest; 1977 May; 71(5):597-606. PubMed ID: 856558 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias. Tanabe T; Yoshikawa H; Furuya H; Goto Y Jpn Circ J; 1988 Mar; 52(3):298-305. PubMed ID: 3373722 [TBL] [Abstract][Full Text] [Related]
25. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram]. Böcker K; Köhler E; Seipel L; Loogen F Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536 [TBL] [Abstract][Full Text] [Related]
26. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease. Moak JP; Smith RT; Garson A J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149 [TBL] [Abstract][Full Text] [Related]
27. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. Manz M; Steinbeck G; Nitsch J; Lüderitz B Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659 [TBL] [Abstract][Full Text] [Related]
28. The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine in ventricular ectopic activity. Myburgh DP; Goldman AP S Afr Med J; 1978 Dec; 54(25):1053-5. PubMed ID: 371028 [TBL] [Abstract][Full Text] [Related]
29. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy. Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613 [TBL] [Abstract][Full Text] [Related]
30. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes. Mehta J; Conti CR Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042 [TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias. Rutledge JC; Harris F; Amsterdam EA J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292 [TBL] [Abstract][Full Text] [Related]
32. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine]. Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118 [TBL] [Abstract][Full Text] [Related]
33. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia. Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. Van Durme JP Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664 [TBL] [Abstract][Full Text] [Related]
35. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine. Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673 [No Abstract] [Full Text] [Related]
36. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias]. Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727 [TBL] [Abstract][Full Text] [Related]